Report Company Directory

MEDLINK INTERNATIONAL INC

MEDLIVE TECHNOLOGY CO LTD

• Medlive Technology Co (2192 HK): 2025: Results In Line; Targets 20% yoy Product Count Growth In 2026. by UOB
• Greater China Daily: Monday, March 30, 2026 by UOB
• Regional Morning Meeting Notes: Monday, March 30, 2026 by UOB
• China Healthcare Bi-Weekly: Resilient Innovation Amid Weak Market Sentiment. by UOB
• Regional Morning Meeting Notes: Monday, March 16, 2026 by UOB
• China Healthcare Bi-Weekly: Competing On The Global Stage Amid Rising Geopolitical Risks. by UOB
• Greater China Daily: Wednesday, February 25, 2026 by UOB
• Regional Morning Meeting Notes: Wednesday, February 25, 2026 by UOB
• Medlive Technology Co (2192 HK) - Leading Physician Platform Propelled By Industry Tailwinds by UOB
• Medlive Technology Co (2192 HK) - Leading Physician Platform Propelled By Industry Tailwinds by UOB

MedMira Inc.

• EQS-News: MedMira provides Progress Update by EQS Group AG
• VYRA™ Product Line Update by GlobeNewsWire
• MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test by GlobeNewsWire
• MedMira reports additional independent performance evaluation results of REVEALCOVID-19™ Total Antibody Test by GlobeNewsWire
• MedMira annonce un partenariat de distribution exclusive avec Webb Diagnostic Technologies et une commande initiale pour son test global de détection d'anticorps REVEALCOVID-19â„¢ aux États-Unis by GlobeNewsWire
• MedMira gibt exklusive Vertriebspartnerschaft mit Webb Diagnostic Technologies für Gesamtantikörpertest REVEALCOVID-19â„¢ in den USA und erste Bestellung bekannt by GlobeNewsWire
• MedMira Announces Exclusive Distribution Partnership with Webb Diagnostic Technologies and Initial Order for REVEALCOVID-19â„¢ Total Antibody Test in the U.S. by GlobeNewsWire
• MedMira fait un point sur les progrès réalisés concernant REVEALCOVID-19â„¢, son test global pour la détection d'anticorps, comprenant l'apposition du marquage CE by GlobeNewsWire
• MedMira gibt Fortschrittsbericht zu seinem REVEALCOVID-19â„¢-Gesamtantikörpertest einschließlich CE-Kennzeichnung bekannt by GlobeNewsWire
• MedMira Announces Progress Update of its REVEALCOVID-19â„¢ Total Antibody Test Including CE Mark by GlobeNewsWire

MEDMIX AG

• European Equity Strategy "Simply Switzerland: Breadth of Fresh Air" Chedda by UBS AG
• Erratum: CDMO Monthly - A Drug's Life: Vol 10. LONN (CHI), SFZN, OXB, 1SXP, GXI (Centor), YPSN, MEDX by Stifel
• European Morning Research Summary by Stifel
• medmix AG "A longer Drug Delivery recovery cycle awaits, but Dental holds..." by UBS AG
• European Morning Research Summary by Stifel
• FY25 review: Healthcare pivot in sharper focus; Medmix's re-rating potential builds by Stifel
• First Read: medmix AG "FY25 earnings call feedback: Back-end-loaded 2026 ahead" by UBS AG
• European Morning Research Summary by Stifel
• FY25 first take: Resilient margins in the face of expected 2025 headwinds by Stifel
• First Read: medmix AG "FY25 results with softer organics, but better margin" by UBS AG

MEDNAX Inc.

• Pediatrix Medical Group Inc.: 1 director by SmartInsider
• Vital Signs: Actionable charts by Vermilion Research
• Vermilion Booster Shots: Attractive bottom-fishing stocks by Vermilion Research
• Vital Signs: Actionable charts by Vermilion Research
• The Weekly Gist: The Russian Chess Death Robot Edition by William Blair
• The Weekly Gist: The What Lies Beneath Edition by William Blair
• ESG Spotlight: Privia Health Group, Inc. by William Blair
• The Weekly Gist: The GOAT of the District Fair Edition by William Blair
• The Weekly Gist: The Hearing Voices From the Past Edition by William Blair
• The Weekly Gist: The Apologies, AI Overlords Edition by William Blair